FNYS
RPTP

First New York Securities’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

First New York Securities’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-355
Closed -$133K – 300
2016
Q3 		$133K Buy
+355
New +$2.52K 0.09% 86

First New York Securities's RPTP Position: Q4 2016 in Review

First New York Securities sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 237,500 shares — an estimated $2.13M sold.

First New York Securities first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $2.13M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • First New York Securities reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • First New York Securities sold 237,500 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $2.13M.
  • First New York Securities first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • First New York Securities's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.13M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.